Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PMM2 | O15305 | 1/20 | 0.36 |
| ▸ | MPI | P34949 | 1/20 | 0.36 |
| ▸ | PHOSPHO1 | Q8TCT1 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18101421 | 0.90 | PMM2 (0.34) | PMM2MPIPHOSPHO1 | |
| SCHEMBL18101417 | 0.89 | ALDH1A1 (0.32) | PTPN1RXFP1 | |
| SCHEMBL18101307 | 0.89 | PTPN1 (0.31) | PTPN1RXFP1 | |
| SCHEMBL20175574 | 0.89 | PMM2 (0.36) | PMM2MPIPHOSPHO1 | |
| SCHEMBL18101366 | 0.89 | KDM4E (0.33) | PTPN1RXFP1 | |
| SCHEMBL18101195 | 0.88 | ATM (0.38) | PTPN1RXFP1 | |
| SCHEMBL20175587 | 0.88 | PMM2 (0.36) | PMM2MPIPHOSPHO1 | |
| SCHEMBL18101168 | 0.86 | PMM2 (0.33) | PMM2MPIPHOSPHO1 | |
| SCHEMBL20175568 | 0.86 | KDM4E (0.35) | PMM2MPIPHOSPHO1 | |
| SCHEMBL20175562 | 0.86 | KDM4E (0.35) | PMM2MPIPHOSPHO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180201621-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-07-19 | — | — | US | disclosed |
| WO-2016153198-A1 | COMPOUND FOR ORGANIC ELECTRONIC DEVICE, ORGANIC ELECTRONIC DEVICE USING SAME, AND ELECTRONIC APPARATUS THEREOF | 덕산네오룩스 주식회사 | 2016-09-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180201621-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF | PIEZO1, OCIAD1, LEF1 | PMM2 3201/4885MPI 4055/4885PHOSPHO1 678/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.